Skyscape Web Viewer : The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs : Main Index

View All
Addiction antidepressants gabapentinoids benzodiazepines and z-drugs Mis-Diagnosis of Withdrawal Effects As Relapse
Adjunctive medication Other Considerations in Tapering Benzodiazepines and Z-Drugs Tapering Benzodiazepines and Z-Drugs in Practice When and Why to Stop Gabapentinoids Other Considerations in Tapering Gabapentinoids Tapering Gabapentinoids in Practice
Adverse effects benzodiazepines and z-drugs Why Deprescribe? antidepressants gabapentinoids
Agomelatine Factors Influencing Development of Withdrawal Effects Agomelatine Stratfiying Risk of Antidepressant Withdrawal
Akathisia antidepressants Further Topics benzodiazepines and z-drugs Specific Issues in Psychiatric Drug Withdrawal
Alcohol withdrawal antidepressants gabapentinoids benzodiazepines and z-drugs
Alprazolam Alprazolam When and Why to Stop Benzodiazepines and Z-Drugs Switching to Longer-Acting Benzodiazepines to Taper Withdrawal Symptoms During Benzodiazepine Maintenance Treatment
Ambivalence Discussing Deprescribing Antidepressants with Patients Discussing Deprescribing Benzodiazepines and Z-Drugs
American Psychiatric Association (APA) Recent Developments in the Understanding of Antidepressant Withdrawal When and Why to Stop Antidepressants Tapering Antidepressants Gradually Withdrawal Symptoms from Benzodiazepines and Z-Drugs
Amitriptyline Amitriptyline Practical Options in Prescribing Gradually Tapering Doses of Antidepressants
Antidepressants
ANTLER study Tapering Antidepressants Gradually Discussing Deprescribing Antidepressants with Patients When and Why to Stop Antidepressants
Anxiety disorders antidepressants gabapentinoids, benzodiazepines and z-drugs
Anxiolytic effects Pathophysiology of Benzodiazepine Withdrawal Syndrome Withdrawal Symptoms from Benzodiazepines and Z-Drugs Hyperbolic Tapering of Benzodiazepines and Z-Drugs When and Why to Stop Benzodiazepines and Z-Drugs
Barriers to deprescribing Tapering Psychiatric Drugs in Practice Barriers and Facilitators to Deprescribing
Bead counting/weighing Practical Options in Prescribing Gradually Tapering Doses of Antidepressants Practical Options for Prescribing Gradually Tapering Doses
Beneficial effects benzodiazepines and z-drugs Tapering Psychiatric Drugs in Practice antidepressants gabapentinoids Why Deprescribe?
Benzodiazepines
Bipolar disorder Distinguishing Benzodiazepine Withdrawal Symptoms from Return of an Underlying Condition When and Why to Stop Benzodiazepines and Z-Drugs Distinguishing Antidepressant Withdrawal Symptoms from New Onset of a Physical or Mental Health Condition Tapering Benzodiazepines and Z-Drugs in Practice When and Why to Stop Gabapentinoids
Bleeding risks
Boxed warning (black box warn- ing) Protracted Benzodiazepine Withdrawal Syndrome Withdrawal Symptoms from Benzodiazepines and Z-Drugs How to Deprescribe Benzodiazepines and Z-Drugs Safely When and Why to Stop Benzodiazepines and Z-Drugs
British National Formulary (BNF) Other Considerations in Tapering Gabapentinoids Other Considerations in Tapering Benzodiazepines and Z-Drugs Practical Options in Prescribing Gradually Tapering Doses of Antidepressants
Buproprion
Buspirone Other Considerations in Tapering Benzodiazepines and Z-Drugs Buspirone
About
α-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid (AMPA)
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines
Cardiovascular risks Clinical Aspects of Antidepressant Withdrawal Distinguishing Benzodiazepine Withdrawal Symptoms from Return of an Underlying Condition Adverse Effects of Antidepressants Discussing Deprescribing Benzodiazepines and Z-Drugs Overview of Gabapentinoid Withdrawal Effects
Characteristic symptomology Clinical Aspects of Psychiatric Drug Withdrawal Distinguishing Antidepressant Withdrawal Symptoms from Relapse
Chlordiazepoxide Chlordiazepoxide Switching to Longer-Acting Benzodiazepines to Taper